{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:56:57Z","timestamp":1794023817559,"version":"4.8.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"am","delay-in-days":252,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","award":["4-FY18-851"],"award-info":[{"award-number":["4-FY18-851"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32MH019113-28"],"award-info":[{"award-number":["5T32MH019113-28"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL007344"],"award-info":[{"award-number":["5T32HL007344"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3UL1TR002537"],"award-info":[{"award-number":["3UL1TR002537"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR024980"],"award-info":[{"award-number":["RR024980"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50HD10355601A1"],"award-info":[{"award-number":["P50HD10355601A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD089940"],"award-info":[{"award-number":["HD089940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD000849"],"award-info":[{"award-number":["HD000849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["22POST30908921"],"award-info":[{"award-number":["22POST30908921"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["19IPLOI34760288"],"award-info":[{"award-number":["19IPLOI34760288"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["18SCG34350001"],"award-info":[{"award-number":["18SCG34350001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.preghy.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T19:24:03Z","timestamp":1659813843000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Selective serotonin reuptake inhibitors and preeclampsia: A quality assessment and meta-analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Serena B","family":"Gumusoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Schickling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Vignato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna A.","family":"Santillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Santillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1552-6909.2006.00115.x","article-title":"Preeclampsia: exposing future cardiovascular risk in mothers and their children","volume":"36","author":"Anderson","year":"2007","journal-title":"J. Obstet. Gynecol. Neonatal. Nurs."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00737-019-01010-1","article-title":"Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis","volume":"23","author":"Caropreso","year":"2020","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0015","doi-asserted-by":"crossref","first-page":"74.e1","DOI":"10.1016\/j.ajog.2017.03.008","article-title":"Preeclampsia and cognitive impairment later in life","volume":"217","author":"Fields","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2022.08.001_b0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/GCO.0b013e32835e0ef5","article-title":"Hypertensive disease of pregnancy and maternal mortality","volume":"25","author":"Lo","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tins.2020.02.003","article-title":"Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure","volume":"43","author":"Gumusoglu","year":"2020","journal-title":"Trends Neurosci."},{"issue":"6","key":"10.1016\/j.preghy.2022.08.001_b0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/HYPERTENSIONAHA.116.07380","article-title":"Breaking a Mother's Heart: Circulating Antiangiogenic Factors and Hypertension During Pregnancy Correlate With Specific Cardiac Dysfunctions","volume":"67","author":"Sandgren","year":"2016","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.preghy.2022.08.001_b0035","doi-asserted-by":"crossref","first-page":"R1062","DOI":"10.1152\/ajpregu.00073.2015","article-title":"Vasopressin: the missing link for preeclampsia?","volume":"309","author":"Sandgren","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.preghy.2022.08.001_b0040","doi-asserted-by":"crossref","unstructured":"D.C. Cornelius, Preeclampsia: From Inflammation to Immunoregulation, Clin. Med. Insights Blood Disord. 11 (2018) 1179545X17752325.","DOI":"10.1177\/1179545X17752325"},{"key":"10.1016\/j.preghy.2022.08.001_b0045","first-page":"17","article-title":"Nonspecific lung diseases in patients with pulmonary tuberculosis (issues of their prevalence, diagnosis and treatment)","author":"Kuklina","year":"2009","journal-title":"Probl Tuberk Bolezn Legk (2)"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/JCP.0000000000000618","article-title":"Is There Any Association Between Use of Antidepressants and Preeclampsia or Gestational Hypertension?: A Systematic Review of Current Studies","volume":"37","author":"Uguz","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.preghy.2022.08.001_b0055","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/pds.4286","article-title":"Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study","volume":"26","author":"Lupattelli","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"7","key":"10.1016\/j.preghy.2022.08.001_b0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11906-021-01155-4","article-title":"The Serotonin-Immune Axis in Preeclampsia","volume":"23","author":"Gumusoglu","year":"2021","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.preghy.2022.08.001_b0065","series-title":"Women's Mood Disorders: A CliniciAn\u2019s Guide to PerinAtAl PsychiAtry","first-page":"5","article-title":"An Overview of Perinatal Mood and Anxiety Disorders: Epidemiology and Etiology","author":"Meltzer-Brody","year":"2021"},{"issue":"9","key":"10.1016\/j.preghy.2022.08.001_b0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/OGX.0000000000000477","article-title":"It Is Time for Routine Screening for Perinatal Mood and Anxiety Disorders in Obstetrics and Gynecology Settings","volume":"72","author":"Accortt","year":"2017","journal-title":"Obstet. Gynecol. Surv."},{"issue":"19","key":"10.1016\/j.preghy.2022.08.001_b0075","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.2174\/1568026618666181115093136","article-title":"Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism","volume":"18","author":"Songtachalert","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0080","first-page":"487","article-title":"Depression and anxiety in early pregnancy and risk for preeclampsia","volume":"95","author":"Kurki","year":"2000","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0085","doi-asserted-by":"crossref","first-page":"e0119018","DOI":"10.1371\/journal.pone.0119018","article-title":"Antenatal Depressive Symptoms and the Risk of Preeclampsia or Operative Deliveries: A Meta-Analysis","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.preghy.2022.08.001_b0090","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/aogs.12175","article-title":"Anxiety and depression following preeclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome. A systematic review","volume":"92","author":"Delahaije","year":"2013","journal-title":"Acta obstetr. et gynecol. Scandinav."},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0095","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41372-019-0346-5","article-title":"Association between maternal serious mental illness and adverse birth outcomes","volume":"39","author":"Heun-Johnson","year":"2019","journal-title":"J. Perinatol."},{"issue":"23","key":"10.1016\/j.preghy.2022.08.001_b0100","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1080\/14767058.2019.1701647","article-title":"Increased rates of adverse perinatal outcomes in women with gestational diabetes and depression","volume":"34","author":"Packer","year":"2021","journal-title":"J. Matern. Fetal Neonatal. Med."},{"issue":"15","key":"10.1016\/j.preghy.2022.08.001_b0105","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.preghy.2022.08.001_b0110","unstructured":"G.A. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, P. Tugwell, The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses, 2009. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"7414","key":"10.1016\/j.preghy.2022.08.001_b0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2022.08.001_b0120","unstructured":"Review Manager Web (RevMan Web), The Cochrane Collaboration, Available at revman.cochrane.org, 2020."},{"issue":"2","key":"10.1016\/j.preghy.2022.08.001_b0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2125.2012.04196.x","article-title":"Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension","volume":"74","author":"De Vera","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12884-018-1825-y","article-title":"Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study","volume":"18","author":"Zakiyah","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"10.1016\/j.preghy.2022.08.001_b0135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/aje\/kwr394","article-title":"Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?","volume":"175","author":"Palmsten","year":"2012","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/ppe.12660","article-title":"Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage","volume":"34","author":"Palmsten","year":"2020","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1092852915000024","article-title":"Antidepressant medication use, depression, and the risk of preeclampsia","volume":"20","author":"Avalos","year":"2015","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1176\/appi.ajp.2008.08060817","article-title":"Selective serotonin reuptake inhibitor use and risk of gestational hypertension","volume":"166","author":"Toh","year":"2009","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.preghy.2022.08.001_b0155","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0160","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/EDE.0b013e31829e0aaa","article-title":"Antidepressant use and risk for preeclampsia","volume":"24","author":"Palmsten","year":"2013","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jrsm.1415","article-title":"A Bayesian approach to assessing small-study effects in meta-analysis of a binary outcome with controlled false positive rate","volume":"11","author":"Shi","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.preghy.2022.08.001_b0170","unstructured":"P. LA, B. DJ, G. Q, Antidepressant use among persons aged 12 and over: United States, 2011\u20132014, National Center for Health Statistics, 2017."},{"key":"10.1016\/j.preghy.2022.08.001_b0175","unstructured":"A.C.o.P. Bulletins--Obstetrics, ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation, Obstet Gynecol 111(4) (2008) 1001-20."},{"key":"10.1016\/j.preghy.2022.08.001_b0180","doi-asserted-by":"crossref","unstructured":"A.C.o.O.a. Gynecologists, ACOG Practice Bulletin No. 87 November 2007: Use of psychiatric medications during pregnancy and lactation, Obstet. Gynecol. 110(5) (2007) 1179-98.","DOI":"10.1097\/01.AOG.0000291559.02462.7f"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1523-536X.2008.00296.x","article-title":"Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression","volume":"36","author":"Goodman","year":"2009","journal-title":"Birth"},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0190","first-page":"e371","article-title":"Challenges for healthcare providers in treating women with psychiatric disorders during pregnancy","volume":"19","author":"Einarson","year":"2012","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"key":"10.1016\/j.preghy.2022.08.001_b0195","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence","author":"Moncrieff","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.preghy.2022.08.001_b0200","article-title":"Management of depression in adults: summary of updated NICE guidance","volume":"378","author":"Kendrick","year":"2022","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.preghy.2022.08.001_b0205","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1517\/14656566.9.14.2497","article-title":"The cost-effectiveness of sertraline in the treatment of depression","volume":"9","author":"Olvey","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"issue":"8","key":"10.1016\/j.preghy.2022.08.001_b0210","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamapsychiatry.2016.0934","article-title":"Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis","volume":"73","author":"Jarde","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1753-6405.2012.00917.x","article-title":"Anti-depressant use during pregnancy in Australia: findings from the Longitudinal Study of Australian Children","volume":"36","author":"Lewis","year":"2012","journal-title":"Aust. N. Z. J. Public Health"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00737-011-0251-1","article-title":"Untreated prenatal maternal depression and the potential risks to offspring: a review","volume":"15","author":"Davalos","year":"2012","journal-title":"Arch. Womens Ment. Health"},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.infbeh.2007.12.004","article-title":"Breastfeeding and antidepressants","volume":"31","author":"Field","year":"2008","journal-title":"Infant. Behav. Dev."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0230","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/imhj.21450","article-title":"Impact of maternal depression on pregnancies and on early attachment","volume":"35","author":"Lefkovics","year":"2014","journal-title":"Infant. Ment. Health J"},{"issue":"10","key":"10.1016\/j.preghy.2022.08.001_b0235","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/da.20299","article-title":"Depression and breastfeeding: which postpartum patients take antidepressant medications?","volume":"25","author":"Battle","year":"2008","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.preghy.2022.08.001_b0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6874-7-15","article-title":"Associations of depression and depressive symptoms with preeclampsia: results from a Peruvian case-control study","volume":"7","author":"Qiu","year":"2007","journal-title":"BMC Womens Health"},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0245","first-page":"230","article-title":"Hormonal basis of mood and postpartum disorders","volume":"3","author":"Parry","year":"2003","journal-title":"Curr. Womens Health Rep."},{"issue":"11","key":"10.1016\/j.preghy.2022.08.001_b0250","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1365-2826.2010.02067.x","article-title":"Resetting the dynamic range of hypothalamic-pituitary-adrenal axis stress responses through pregnancy","volume":"22","author":"Brunton","year":"2010","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.preghy.2022.08.001_b0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2018.02.009","article-title":"Association of depression with body mass index classification, metabolic disease, and lifestyle: A web-based survey involving 11,876 Japanese people","volume":"102","author":"Hidese","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.preghy.2022.08.001_b0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.12738","article-title":"The interface of depression and cardiovascular disease: therapeutic implications","volume":"1345","author":"Seligman","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.preghy.2022.08.001_b0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-3-319-77932-4_28","article-title":"Cardiovascular Sequels During and After Preeclampsia","volume":"1065","author":"Paauw","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr. Diab. Rep."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0275","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jcpp.13004","article-title":"Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research","volume":"60","author":"Sujan","year":"2019","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"25","key":"10.1016\/j.preghy.2022.08.001_b0280","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","article-title":"Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism","volume":"369","author":"Hviid","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2021.04.002","article-title":"Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders","volume":"90","author":"Ames","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.preghy.2022.08.001_b0290","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4088\/JCP.v59n1002","article-title":"Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients","volume":"59","author":"Thase","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.preghy.2022.08.001_b0295","first-page":"574","article-title":"Cardiovascular safety in depressed patients: focus on venlafaxine","volume":"56","author":"Feighner","year":"1995","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0300","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ecl.2019.08.013","article-title":"Drug-Induced Hypertension","volume":"48","author":"Foy","year":"2019","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/a-1717-2381","article-title":"Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?","volume":"55","author":"Mueller","year":"2022","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.preghy.2022.08.001_b0310","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study","volume":"26","author":"Hoertel","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.preghy.2022.08.001_b0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/09513599709152568","article-title":"Significant decrease of maternal serum serotonin levels in singleton pregnancies complicated by the HELLP syndrome","volume":"11","author":"Backe","year":"1997","journal-title":"Gynecol. Endocrinol."},{"issue":"6","key":"10.1016\/j.preghy.2022.08.001_b0320","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0002-9378(96)70104-7","article-title":"Novel appearance of placental nuclear monoamine oxidase: biochemical and histochemical evidence for hyperserotonomic state in preeclampsia-eclampsia","volume":"175","author":"Gujrati","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2022.08.001_b0325","article-title":"Comparisons of vascular responses to vasoconstrictors in human placenta in preeclampsia between preterm and later term","author":"Feng","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"5\u20136","key":"10.1016\/j.preghy.2022.08.001_b0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.vph.2011.07.006","article-title":"Reduced placental vascular reactivity to 5-hydroxytryptamine in pre-eclampsia and the status of 5HT(2A) receptors","volume":"55","author":"Ugun-Klusek","year":"2011","journal-title":"Vasc.Pharmacol."},{"issue":"9","key":"10.1016\/j.preghy.2022.08.001_b0335","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1038\/tp.2016.156","article-title":"Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model","volume":"6","author":"Lopez-Vilchez","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0340","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0301-2115(00)00367-5","article-title":"Pathophysiology of preeclampsia and the role of serotonin","volume":"95","author":"Bolte","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"4 Suppl","key":"10.1016\/j.preghy.2022.08.001_b0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1067\/mhj.2000.109978","article-title":"Are platelets the link between depression and ischemic heart disease?","volume":"140","author":"Nemeroff","year":"2000","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0350","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1445-5994.2008.01794.x","article-title":"Platelet function in patients with major depression","volume":"39","author":"Ziegelstein","year":"2009","journal-title":"Intern Med J"},{"issue":"1\u20132","key":"10.1016\/j.preghy.2022.08.001_b0355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth-Evenzal","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.preghy.2022.08.001_b0360","doi-asserted-by":"crossref","unstructured":"K. Taniguchi, Vasospastic action of serotonin on the umbilical artery in normal and preeclamptic patients, J. Obstet. Gynaecol. (Tokyo 1995) 21(1) (1995) 37-42.","DOI":"10.1111\/j.1447-0756.1995.tb00895.x"},{"issue":"3 Pt 1","key":"10.1016\/j.preghy.2022.08.001_b0365","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9378(99)70268-1","article-title":"Reactivities to serotonin and histamine in umbilical and placental vessels during the third trimester after normotensive pregnancies and pregnancies complicated by preeclampsia","volume":"180","author":"Bertrand","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0370","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1203\/00006450-200204000-00007","article-title":"Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth","volume":"51","author":"Morrison","year":"2002","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0375","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1753944715624853","article-title":"The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia","volume":"10","author":"Saleh","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0380","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1054\/chec.1999.0059","article-title":"Effects of SSRI antidepressant treatment upon mood status and blood pressure reactivity to demand in coronary patients","volume":"4","author":"Hallas","year":"2000","journal-title":"Coronary Health Care"},{"issue":"Suppl 1","key":"10.1016\/j.preghy.2022.08.001_b0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00053425","article-title":"The role of serotonin in the preeclampsia-eclampsia syndrome","volume":"4","author":"Weiner","year":"1990","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0390","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0002-9378(87)90345-0","article-title":"The role of serotonin in the genesis of hypertension in preeclampsia","volume":"156","author":"Weiner","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.preghy.2022.08.001_b0395","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11920-013-0400-5","article-title":"Inflammation, heart disease, and depression","volume":"15","author":"Halaris","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0400","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9149(01)02236-6","article-title":"Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes","volume":"89","author":"Shimbo","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0405","first-page":"511","article-title":"Serotonergic mechanisms enhance platelet-mediated thrombogenicity","volume":"102","author":"Galan","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"16","key":"10.1016\/j.preghy.2022.08.001_b0410","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1503\/cmaj.100912","article-title":"Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction","volume":"183","author":"Labos","year":"2011","journal-title":"Can. Med. Assoc. J."},{"issue":"6","key":"10.1016\/j.preghy.2022.08.001_b0415","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","article-title":"A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation","volume":"126","author":"Tseng","year":"2010","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0420","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/phrs.2001.0817","article-title":"Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors","volume":"43","author":"Serebruany","year":"2001","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0425","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mcp.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"issue":"23","key":"10.1016\/j.preghy.2022.08.001_b0430","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1523\/JNEUROSCI.19-23-10494.1999","article-title":"Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level","volume":"19","author":"Benmansour","year":"1999","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0435","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2005.10.075","article-title":"Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors","volume":"1067","author":"Yamauchi","year":"2006","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0440","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12884-019-2285-8","article-title":"Use of antidepressants and anxiolytics in early pregnancy and the risk of preeclampsia and gestational hypertension: a prospective study","volume":"19","author":"Bernard","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0445","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0181","article-title":"Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy","volume":"138","author":"Norby","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0450","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1067\/mob.2003.156","article-title":"Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia","volume":"188","author":"Kudo","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0455","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5482\/HAMO-14-11-0073","article-title":"Platelet serotonin modulates immune functions","volume":"36","author":"Mauler","year":"2016","journal-title":"Hamostaseologie"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0460","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1871527319666200102100307","article-title":"Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Nai ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory Cytokines","volume":"19","author":"Al-Hakeim","year":"2020","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.preghy.2022.08.001_b0465","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.psyneuen.2016.11.031","article-title":"Oxidative stress, inflammation and treatment response in major depression","volume":"76","author":"Lindqvist","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.preghy.2022.08.001_b0470","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2019.06.001","article-title":"Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder","volume":"81","author":"Hou","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0475","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0963721412453720","article-title":"The Psychoneuroimmunology of Stress in Pregnancy","volume":"21","author":"Coussons-Read","year":"2012","journal-title":"Curr. Direct. Psychol. Sci."},{"issue":"9","key":"10.1016\/j.preghy.2022.08.001_b0480","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1089\/jwh.2007.0725","article-title":"The psychoneuroimmunology of postpartum depression","volume":"17","author":"Corwin","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"issue":"10","key":"10.1016\/j.preghy.2022.08.001_b0485","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.psyneuen.2013.03.019","article-title":"Perinatal depression\u2013the fourth inflammatory morbidity of pregnancy?: Theory and literature review","volume":"38","author":"Osborne","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.preghy.2022.08.001_b0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbi.2017.02.010","article-title":"Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases","volume":"62","author":"Brooks","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/jir.2006.26.53","article-title":"Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells","volume":"26","author":"Shirey","year":"2006","journal-title":"J. Interferon Cytokine Res."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0500","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jb\/mvj072","volume":"139","author":"Fujigaki","year":"2006","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0505","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12974-019-1509-1","article-title":"The antidepressant effects of GM-CSF are mediated by the reduction of TLR4\/NF-kB-induced IDO expression","volume":"16","author":"Hemmati","year":"2019","journal-title":"J. Neuroinflammat."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0510","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/HYPERTENSIONAHA.114.03848","article-title":"Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model","volume":"64","author":"Santillan","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0515","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.psyneuen.2007.12.009","article-title":"The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants","volume":"33","author":"Stewart","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.preghy.2022.08.001_b0520","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10995-016-1919-y","article-title":"Physical Activity During Pregnancy and Subsequent Risk of Preeclampsia and Gestational Hypertension: A Case Control Study","volume":"20","author":"Spracklen","year":"2016","journal-title":"Matern. Child Health J."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0525","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12529-010-9075-z","article-title":"Sedentary behavior and depression among adults: a review","volume":"17","author":"Teychenne","year":"2010","journal-title":"Int. J. Behav. Med."},{"issue":"12","key":"10.1016\/j.preghy.2022.08.001_b0530","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.biopsych.2006.06.015","article-title":"Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors","volume":"60","author":"Papakostas","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.preghy.2022.08.001_b0535","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00001648-199605000-00005","article-title":"Job stress and preeclampsia","volume":"7","author":"Klonoff-Cohen","year":"1996","journal-title":"Epidemiology"},{"issue":"225","key":"10.1016\/j.preghy.2022.08.001_b0540","doi-asserted-by":"crossref","first-page":"re5","DOI":"10.1126\/stke.2252004re5","article-title":"Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention","volume":"2004","author":"Charney","year":"2004","journal-title":"Sci STKE"},{"issue":"5","key":"10.1016\/j.preghy.2022.08.001_b0545","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9378(84)90023-1","article-title":"Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist","volume":"149","author":"Weiner","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9087","key":"10.1016\/j.preghy.2022.08.001_b0550","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(97)06408-8","article-title":"Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia","volume":"350","author":"Steyn","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.001_b0555","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0301-2115(00)00368-7","article-title":"Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers","volume":"95","author":"Bolte","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"10.1016\/j.preghy.2022.08.001_b0560","first-page":"525","article-title":"Ketanserin and hydralazine in hypertension in pregnancy\u2013a randomised double-blind trial","volume":"85","author":"Rossouw","year":"1995","journal-title":"S. Afr. Med. J."},{"issue":"2","key":"10.1016\/j.preghy.2022.08.001_b0565","first-page":"65","article-title":"Effects of ketanserin\u2013a serotonin receptor antagonist\u2013on placental blood flow, placental weight and fetal weight of spontaneously hypertensive rats and normal Wistar Kyoto rats","volume":"32","author":"Furuhashi","year":"1991","journal-title":"Gynecol. Obstet. Invest."},{"issue":"4","key":"10.1016\/j.preghy.2022.08.001_b0570","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/HYPERTENSIONAHA.107.094540","article-title":"Pregnant rats treated with a serotonin precursor have reduced fetal weight and lower plasma volume and kallikrein levels","volume":"50","author":"Salas","year":"2007","journal-title":"Hypertension"},{"issue":"Suppl 5","key":"10.1016\/j.preghy.2022.08.001_b0575","first-page":"S48","article-title":"Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs","volume":"17","author":"Robertson","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"9","key":"10.1016\/j.preghy.2022.08.001_b0580","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00006254-200009000-00024","article-title":"Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin","volume":"55","author":"Steyn","year":"2000","journal-title":"Obstet. Gynecol. Surv."},{"issue":"12","key":"10.1016\/j.preghy.2022.08.001_b0585","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0002-9149(89)90051-9","article-title":"Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin","volume":"63","author":"Zehender","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.preghy.2022.08.001_b0590","unstructured":"U. Ellis, Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions: Ketanserin, Choice: Current Reviews for Academic Libraries 44(9) (2007) 413."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:26:04Z","timestamp":1778840764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778922000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":118,"alternative-id":["S2210778922000836"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2022.08.001","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective serotonin reuptake inhibitors and preeclampsia: A quality assessment and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}